l General Information |
Product
Name | BGP-15 dihydrochloride |
General
description | BGP-15 dihydrochloride is a nicotinic
amidoxime derivative with PARP inhibitory activity. |
Synonym | N'-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidamide; dihydrochloride |
Purity | ≥99.0%(HPLC) | CAS Number | 66611-37-8 |
Formula | C14H22N4O2·2HCl | Molecular
Weight | 351.27 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Pale yellow solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | ≥50mg/mL |
Water | ≥50mg/mL |
l Biological Information |
Biochem/Physiol
Actions | BGP-15 is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects
against ischemia-reperfusion injury. |
l Packaging & Storage |
Packaging | 5mg; 10mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This
product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
